{"id":33609,"date":"2025-05-16T15:11:08","date_gmt":"2025-05-16T07:11:08","guid":{"rendered":"https:\/\/flcube.com\/?p=33609"},"modified":"2025-05-16T15:11:09","modified_gmt":"2025-05-16T07:11:09","slug":"beijing-balance-medicals-renato-system-gets-nmpa-approval-for-valve-in-valve-therapy","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=33609","title":{"rendered":"Beijing Balance Medical&#8217;s Renato System Gets NMPA Approval for Valve-in-Valve Therapy"},"content":{"rendered":"\n<p>China&#8217;s Beijing Balance Medical Technology Co., Ltd (<a href=\"https:\/\/www.google.com\/finance\/quote\/688198:SHA\">SHA: 688198<\/a>) has obtained market authorization from China&#8217;s National Medical Products Administration (NMPA) for its Renato Transcatheter Valve-in-Valve System. This is the world&#8217;s first globally commercialized interventional device based on valve-in-valve (ViV) therapy, targeting high-surgical-risk patients with failed bioprosthetic valve implants. The system addresses conditions such as structural valve deterioration (SVD), prosthesis-patient mismatch (PPM), and valve thrombosis.<\/p>\n\n\n\n<p><strong>Product Design and Application<\/strong><br>The Renato system is anatomically designed for artificial bioprosthetic valves. Its structure and characteristics enable secure anchoring at the inflow annulus of the bioprosthetic valve. Based on standardized circular inflow designs and inner diameter specifications of all implantable bioprosthetic valves, the product is designed in 2mm diameter increments to achieve precise valve-in-valve anchoring.<\/p>\n\n\n\n<p><strong>Patient benefits and lifecycle management<\/strong><br>The system provides re-interventional treatment for patients with previously implanted bioprosthetic valves, effectively extending valve durability. It addresses concerns for younger Chinese patients opting for bioprostheses and accommodates diverse inner diameter requirements. This innovation complements the company\u2019s previously launched limited-expansion bioprosthetic valve, enabling multiple re-interventional therapies and aligning with the clinical need for comprehensive lifecycle management of valvular heart disease.<a href=\"https:\/\/flcube.com\/\">-Fineline Info &amp; Tech<\/a><\/p>\n\n\n\n<div data-wp-interactive=\"core\/file\" class=\"wp-block-file\"><object data-wp-bind--hidden=\"!state.hasPdfPreview\" hidden class=\"wp-block-file__embed\" data=\"https:\/\/flcube.com\/wp-content\/uploads\/2025\/05\/688198_20250516_FBGH.pdf\" type=\"application\/pdf\" style=\"width:100%;height:600px\" aria-label=\"Embed of 688198_20250516_FBGH.\"><\/object><a id=\"wp-block-file--media-eb51016b-50f1-4ef8-8bad-bd3f3cf13a11\" href=\"https:\/\/flcube.com\/wp-content\/uploads\/2025\/05\/688198_20250516_FBGH.pdf\">688198_20250516_FBGH<\/a><a href=\"https:\/\/flcube.com\/wp-content\/uploads\/2025\/05\/688198_20250516_FBGH.pdf\" class=\"wp-block-file__button wp-element-button\" download aria-describedby=\"wp-block-file--media-eb51016b-50f1-4ef8-8bad-bd3f3cf13a11\">Download<\/a><\/div>\n","protected":false},"excerpt":{"rendered":"<p>China&#8217;s Beijing Balance Medical Technology Co., Ltd (SHA: 688198) has obtained market authorization from China&#8217;s&#8230;<\/p>\n","protected":false},"author":1,"featured_media":33612,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAownpewDA:productID":"","_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[7,22],"tags":[2408,69,15,1100],"class_list":["post-33609","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-company","category-medical-device","tag-balance-medical-technology","tag-cvd","tag-product-approvals","tag-sha-688198"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v23.6 (Yoast SEO v27.5) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Beijing Balance Medical&#039;s Renato System Gets NMPA Approval for Valve-in-Valve Therapy - Insight, China&#039;s Pharmaceutical Industry<\/title>\n<meta name=\"description\" content=\"China&#039;s Beijing Balance Medical Technology Co., Ltd (SHA: 688198) has obtained market authorization from China\u2019s National Medical Products Administration (NMPA) for its Renato Transcatheter Valve-in-Valve System. This is the world&#039;s first globally commercialized interventional device based on valve-in-valve (ViV) therapy, targeting high-surgical-risk patients with failed bioprosthetic valve implants. The system addresses conditions such as structural valve deterioration (SVD), prosthesis-patient mismatch (PPM), and valve thrombosis.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flcube.com\/?p=33609\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Beijing Balance Medical&#039;s Renato System Gets NMPA Approval for Valve-in-Valve Therapy\" \/>\n<meta property=\"og:description\" content=\"China&#039;s Beijing Balance Medical Technology Co., Ltd (SHA: 688198) has obtained market authorization from China\u2019s National Medical Products Administration (NMPA) for its Renato Transcatheter Valve-in-Valve System. This is the world&#039;s first globally commercialized interventional device based on valve-in-valve (ViV) therapy, targeting high-surgical-risk patients with failed bioprosthetic valve implants. The system addresses conditions such as structural valve deterioration (SVD), prosthesis-patient mismatch (PPM), and valve thrombosis.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flcube.com\/?p=33609\" \/>\n<meta property=\"og:site_name\" content=\"Insight, China&#039;s Pharmaceutical Industry\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61566606313834\" \/>\n<meta property=\"article:published_time\" content=\"2025-05-16T07:11:08+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-05-16T07:11:09+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flcube.com\/wp-content\/uploads\/2025\/05\/1610.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1080\" \/>\n\t<meta property=\"og:image:height\" content=\"608\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Fineline Cube\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fineline Cube\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=33609#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=33609\"},\"author\":{\"name\":\"Fineline Cube\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\"},\"headline\":\"Beijing Balance Medical&#8217;s Renato System Gets NMPA Approval for Valve-in-Valve Therapy\",\"datePublished\":\"2025-05-16T07:11:08+00:00\",\"dateModified\":\"2025-05-16T07:11:09+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=33609\"},\"wordCount\":207,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=33609#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/05\\\/1610.webp\",\"keywords\":[\"Balance Medical Technology\",\"CVD\",\"Product approvals\",\"SHA: 688198\"],\"articleSection\":[\"Company\",\"Medical Device\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=33609#respond\"]}],\"copyrightYear\":\"2025\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=33609\",\"url\":\"https:\\\/\\\/flcube.com\\\/?p=33609\",\"name\":\"Beijing Balance Medical's Renato System Gets NMPA Approval for Valve-in-Valve Therapy - Insight, China&#039;s Pharmaceutical Industry\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=33609#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=33609#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/05\\\/1610.webp\",\"datePublished\":\"2025-05-16T07:11:08+00:00\",\"dateModified\":\"2025-05-16T07:11:09+00:00\",\"description\":\"China's Beijing Balance Medical Technology Co., Ltd (SHA: 688198) has obtained market authorization from China\u2019s National Medical Products Administration (NMPA) for its Renato Transcatheter Valve-in-Valve System. This is the world's first globally commercialized interventional device based on valve-in-valve (ViV) therapy, targeting high-surgical-risk patients with failed bioprosthetic valve implants. The system addresses conditions such as structural valve deterioration (SVD), prosthesis-patient mismatch (PPM), and valve thrombosis.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=33609#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=33609\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=33609#primaryimage\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/05\\\/1610.webp\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/05\\\/1610.webp\",\"width\":1080,\"height\":608,\"caption\":\"Beijing Balance Medical's Renato System Gets NMPA Approval for Valve-in-Valve Therapy\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=33609#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/flcube.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Beijing Balance Medical&#8217;s Renato System Gets NMPA Approval for Valve-in-Valve Therapy\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"name\":\"Insight, China's Pharmaceutical Industry\",\"description\":\"Fineline Insights, Pharma Clarity\",\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/flcube.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\",\"name\":\"Fineline Infomation and Technology\",\"alternateName\":\"Fineline Info & Tech\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"width\":2560,\"height\":1894,\"caption\":\"Fineline Infomation and Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61566606313834\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\",\"name\":\"Fineline Cube\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"caption\":\"Fineline Cube\"},\"sameAs\":[\"https:\\\/\\\/flcube.com\"],\"url\":\"https:\\\/\\\/flcube.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Beijing Balance Medical's Renato System Gets NMPA Approval for Valve-in-Valve Therapy - Insight, China&#039;s Pharmaceutical Industry","description":"China's Beijing Balance Medical Technology Co., Ltd (SHA: 688198) has obtained market authorization from China\u2019s National Medical Products Administration (NMPA) for its Renato Transcatheter Valve-in-Valve System. This is the world's first globally commercialized interventional device based on valve-in-valve (ViV) therapy, targeting high-surgical-risk patients with failed bioprosthetic valve implants. The system addresses conditions such as structural valve deterioration (SVD), prosthesis-patient mismatch (PPM), and valve thrombosis.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flcube.com\/?p=33609","og_locale":"en_US","og_type":"article","og_title":"Beijing Balance Medical's Renato System Gets NMPA Approval for Valve-in-Valve Therapy","og_description":"China's Beijing Balance Medical Technology Co., Ltd (SHA: 688198) has obtained market authorization from China\u2019s National Medical Products Administration (NMPA) for its Renato Transcatheter Valve-in-Valve System. This is the world's first globally commercialized interventional device based on valve-in-valve (ViV) therapy, targeting high-surgical-risk patients with failed bioprosthetic valve implants. The system addresses conditions such as structural valve deterioration (SVD), prosthesis-patient mismatch (PPM), and valve thrombosis.","og_url":"https:\/\/flcube.com\/?p=33609","og_site_name":"Insight, China&#039;s Pharmaceutical Industry","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61566606313834","article_published_time":"2025-05-16T07:11:08+00:00","article_modified_time":"2025-05-16T07:11:09+00:00","og_image":[{"width":1080,"height":608,"url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/05\/1610.webp","type":"image\/png"}],"author":"Fineline Cube","twitter_card":"summary_large_image","twitter_description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","twitter_misc":{"Written by":"Fineline Cube","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flcube.com\/?p=33609#article","isPartOf":{"@id":"https:\/\/flcube.com\/?p=33609"},"author":{"name":"Fineline Cube","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a"},"headline":"Beijing Balance Medical&#8217;s Renato System Gets NMPA Approval for Valve-in-Valve Therapy","datePublished":"2025-05-16T07:11:08+00:00","dateModified":"2025-05-16T07:11:09+00:00","mainEntityOfPage":{"@id":"https:\/\/flcube.com\/?p=33609"},"wordCount":207,"commentCount":0,"publisher":{"@id":"https:\/\/flcube.com\/#organization"},"image":{"@id":"https:\/\/flcube.com\/?p=33609#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/05\/1610.webp","keywords":["Balance Medical Technology","CVD","Product approvals","SHA: 688198"],"articleSection":["Company","Medical Device"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/flcube.com\/?p=33609#respond"]}],"copyrightYear":"2025","copyrightHolder":{"@id":"https:\/\/flcube.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/flcube.com\/?p=33609","url":"https:\/\/flcube.com\/?p=33609","name":"Beijing Balance Medical's Renato System Gets NMPA Approval for Valve-in-Valve Therapy - Insight, China&#039;s Pharmaceutical Industry","isPartOf":{"@id":"https:\/\/flcube.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/flcube.com\/?p=33609#primaryimage"},"image":{"@id":"https:\/\/flcube.com\/?p=33609#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/05\/1610.webp","datePublished":"2025-05-16T07:11:08+00:00","dateModified":"2025-05-16T07:11:09+00:00","description":"China's Beijing Balance Medical Technology Co., Ltd (SHA: 688198) has obtained market authorization from China\u2019s National Medical Products Administration (NMPA) for its Renato Transcatheter Valve-in-Valve System. This is the world's first globally commercialized interventional device based on valve-in-valve (ViV) therapy, targeting high-surgical-risk patients with failed bioprosthetic valve implants. The system addresses conditions such as structural valve deterioration (SVD), prosthesis-patient mismatch (PPM), and valve thrombosis.","breadcrumb":{"@id":"https:\/\/flcube.com\/?p=33609#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flcube.com\/?p=33609"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/?p=33609#primaryimage","url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/05\/1610.webp","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/05\/1610.webp","width":1080,"height":608,"caption":"Beijing Balance Medical's Renato System Gets NMPA Approval for Valve-in-Valve Therapy"},{"@type":"BreadcrumbList","@id":"https:\/\/flcube.com\/?p=33609#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flcube.com\/"},{"@type":"ListItem","position":2,"name":"Beijing Balance Medical&#8217;s Renato System Gets NMPA Approval for Valve-in-Valve Therapy"}]},{"@type":"WebSite","@id":"https:\/\/flcube.com\/#website","url":"https:\/\/flcube.com\/","name":"Insight, China's Pharmaceutical Industry","description":"Fineline Insights, Pharma Clarity","publisher":{"@id":"https:\/\/flcube.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flcube.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/flcube.com\/#organization","name":"Fineline Infomation and Technology","alternateName":"Fineline Info & Tech","url":"https:\/\/flcube.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","width":2560,"height":1894,"caption":"Fineline Infomation and Technology"},"image":{"@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61566606313834"]},{"@type":"Person","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a","name":"Fineline Cube","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","caption":"Fineline Cube"},"sameAs":["https:\/\/flcube.com"],"url":"https:\/\/flcube.com\/?author=1"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/05\/1610.webp","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/33609","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=33609"}],"version-history":[{"count":1,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/33609\/revisions"}],"predecessor-version":[{"id":33613,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/33609\/revisions\/33613"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/media\/33612"}],"wp:attachment":[{"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=33609"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=33609"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=33609"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}